Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2–3 diarrhoea

Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2–3 diarrhoea

Bibliographic Details
Main Authors:	Reis, Tina, Khazzaka, Edwin, Welzel, Grit, Wenz, Frederik, Hofheinz, Ralf–Dieter, Mai, Sabine
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324657/

Similar Items

The influence of smoking and other risk factors on the outcome after radiochemotherapy for anal cancer
by: Mai, Sabine Kathrin, et al.
Published: (2007)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
by: Spolverato, Gaya, et al.
Published: (2011)

Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
by: Schiffmann, Leif, et al.
Published: (2013)

Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials
by: Kripp, M., et al.
Published: (2015)

Impact of adjuvant chemotherapy on patients with ypT0–2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital
by: Christian Galata, et al.
Published: (2018-08-01)

Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy
by: Schwaab, Juliana, et al.
Published: (2011)

Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors
by: Ferrigno, Robson, et al.
Published: (2006)

Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery
by: Derbel, Olfa, et al.
Published: (2013)

Diffusion-Weighted Magnetic Resonance Application in Response Prediction before, during, and after Neoadjuvant Radiochemotherapy in Primary Rectal Cancer Carcinoma
by: Musio, Daniela, et al.
Published: (2013)

Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis
by: Schiffmann, Leif, et al.
Published: (2013)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
by: Rendl, Gundula, et al.
Published: (2014)

Radiochemotherapy
Published: (1998)

Prognostic Impact of mRNA Expression Levels of HER1–4 (ERBB1–4) in Patients with Locally Advanced Rectal Cancer
by: Kripp, Melanie, et al.
Published: (2016)

A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer
by: Sperk, Elena, et al.
Published: (2014)

Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS)
by: Kraus-Tiefenbacher, Uta, et al.
Published: (2012)

Squamous Cell Carcinoma of the Pancreas in a Patient with Germline BRCA2 Mutation-Response to Neoadjuvant Radiochemotherapy
by: Schultheis, Anne M., et al.
Published: (2014)

Correction to: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
by: Julia Slotta-Huspenina, et al.
Published: (2018-05-01)

MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
by: Julia Slotta-Huspenina, et al.
Published: (2018-04-01)

Neoadjuvant Treatment in Rectal Cancer: Actual Status
by: Garajová, Ingrid, et al.
Published: (2011)

Neoadjuvant treatment of rectal cancer: where are we now?
by: Kalyan, Aparna, et al.
Published: (2016)

Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma
by: Oblak, Irena, et al.
Published: (2014)

Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
by: Dellas, Kathrin, et al.
Published: (2013)

ALDH1 is an independent prognostic factor for patients with stages II–III rectal cancer after receiving radiochemotherapy
by: Deng, Y, et al.
Published: (2014)

Prognostic significance of tumor regression in locally advanced rectal cancer after preoperative radiochemotherapy
by: Omejc Mirko, et al.
Published: (2017-12-01)

Association Between the Cytogenetic Profile of Tumor Cells and Response to Preoperative Radiochemotherapy in Locally Advanced Rectal Cancer
by: González-González, María, et al.
Published: (2014)

Detection of morphologic alterations in rectal carcinoma following preoperative radiochemotherapy based on multiphoton microscopy imaging
by: Li, Lianhuang, et al.
Published: (2015)

Phospho-ERK1/2 levels in cancer cell nuclei predict responsiveness to radiochemotherapy of rectal adenocarcinoma
by: Holck, Susanne, et al.
Published: (2015)

A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design
by: Lefevre, Jérémie H, et al.
Published: (2013)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
by: Garsed, Klara, et al.
Published: (2013)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
by: Garsed, Klara, et al.
Published: (2014)

Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
by: Niewald, Marcus, et al.
Published: (2011)

TARGIT-E(lderly)—Prospective phase II study of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer
by: Neumaier, Christian, et al.
Published: (2012)

Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A
by: Welzel, Grit, et al.
Published: (2013)

Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity
by: Shelan, Mohamed, et al.
Published: (2013)

A Retrospective Study on Radiotherapy and Radiochemotherapy in Esophageal Cancer
by: Kim, Chang-Min, et al.
Published: (1988)

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction
by: Moehler, Markus, et al.
Published: (2013)

The Prognostic Value of Irradiated Lung Volumes on the Prediction of Intra-/ Post-Operative Mortality in Patients after Neoadjuvant Radiochemotherapy for Esophageal Cancer. A Retrospective Multicenter Study.
by: Kup, Philipp Günther, et al.
Published: (2015)

Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
by: McCoy, M., et al.
Published: (2015)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
by: Molinari, Chiara, et al.
Published: (2011)

Magnetic Resonance Imaging to Evaluate Neoadjuvant Therapy Effects on Rectal Carcinoma
by: Amela Sofić, et al.
Published: (2015-01-01)